Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L K Surles
Paradoxical Enhancement of Atherosclerosis by Probucol Treatment in Apolipoprotein E-Deficient Mice.
Journal of Clinical Investigation
Medicine
Related publications
597. Therapy of Atherosclerosis in Apolipoprotein E-Deficient Mice
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Acyl-CoA:Cholesterol Acyltransferase Inhibition Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Inhibition of Endoplasmic Reticulum Stress and Atherosclerosis by 2-Aminopurine in Apolipoprotein E-Deficient Mice
ISRN Pharmacology
Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
Mediators of Inflammation
Immunology
Cell Biology
Deficiency of Acyl CoA:cholesterol Acyltransferase 2 Prevents Atherosclerosis in Apolipoprotein E-Deficient Mice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Proatherogenic and Antiatherogenic Effects of Probucol and Phytosterols in Apolipoprotein E Deficient Mice : Possible Mechanisms of Action
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice
Scientific Reports
Multidisciplinary
Atherosclerosis: The Apolipoprotein E-Deficient Mouse Model Revisited
Microscopy and Microanalysis
Instrumentation